MPEG LA
CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles
Premium
As MPEG LA tries to complete its larger CRISPR IP patent pool, smaller license agreements continue and a mini-pool has emerged between key players.
NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing
Premium
Several high-profile research organizations, including the National Institutes of Health, have contributed a number of personalized medicine-focused biomarker- and diagnostics-related patents to a new intellectual property licensing "supermarket" called Librassay.
Originally published Feb. 17.
By Turna Ray
In Wake of Myriad Decision, Some Debate Licensing Models for Gene Patents, While Some Question Value
Premium
Since a US federal district court last month deemed seven of Myriad Genetics' BRCA patents invalid, certain industry players have taken small steps toward fostering more collaboration around gene patents while others have raised questions about the value of patenting genes altogether amid rapid advances in whole-genome sequencing.